Vanguard Group
KRMD icon

Vanguard Group’s KORU Medical Systems KRMD Stock Holding History

Vanguard Group’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.8M Buy
2,207,698
+61,926
+3% +$297K ﹤0.01% 2837
2025
Q3 		$8.22M Buy
2,145,772
+60,109
+3% +$230K ﹤0.01% 3077
2025
Q2 		$7.47M Buy
2,085,663
+321,656
+18% +$914K ﹤0.01% 3057
2025
Q1 		$4.48M Buy
1,764,007
+6,482
+0.4% +$24.1K ﹤0.01% 3223
2024
Q4 		$6.77M Sell
1,757,525
-25,276
-1% -$82.1K ﹤0.01% 3142
2024
Q3 		$4.87M Hold
1,782,801
– – ﹤0.01% 3279
2024
Q2 		$4.72M Sell
1,782,801
-178,963
-9% -$409K ﹤0.01% 3282
2024
Q1 		$4.63M Buy
1,961,764
+51,890
+3% +$111K ﹤0.01% 3328
2023
Q4 		$4.69M Buy
1,909,874
+21,286
+1% +$50.7K ﹤0.01% 3314
2023
Q3 		$5.1M Buy
1,888,588
+51,321
+3% +$141K ﹤0.01% 3237
2023
Q2 		$6.34M Buy
1,837,267
+143,925
+8% +$565K ﹤0.01% 3191
2023
Q1 		$7.15M Buy
1,693,342
+346,760
+26% +$1.36M ﹤0.01% 3132
2022
Q4 		$4.81M Buy
1,346,582
+678
+0.1% +$1.87K ﹤0.01% 3328
2022
Q3 		$3M Buy
1,345,904
+4,600
+0.3% +$11.4K ﹤0.01% 3584
2022
Q2 		$3.39M Hold
1,341,304
– – ﹤0.01% 3565
2022
Q1 		$3.84M Sell
1,341,304
-5,238
-0.4% -$15.7K ﹤0.01% 3653
2021
Q4 		$4.04M Buy
1,346,542
+1,812
+0.1% +$5.55K ﹤0.01% 3726
2021
Q3 		$3.83M Sell
1,344,730
-13,682
-1% -$45.3K ﹤0.01% 3807
2021
Q2 		$6.29M Sell
1,358,412
-352,560
-21% -$1.38M ﹤0.01% 3470
2021
Q1 		$6.02M Buy
1,710,972
+76,133
+5% +$330K ﹤0.01% 3431
2020
Q4 		$9.84M Buy
1,634,839
+328,760
+25% +$1.84M ﹤0.01% 3004
2020
Q3 		$9.43M Sell
1,306,079
-23,926
-2% -$212K ﹤0.01% 2817
2020
Q2 		$11.9M Buy
1,330,005
+266,165
+25% +$2.69M ﹤0.01% 2677
2020
Q1 		$7.98M Buy
1,063,840
+242,207
+29% +$1.63M ﹤0.01% 2717
2019
Q4 		$5.37M Buy
+821,633
New +$4.01M ﹤0.01% 3148

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $109M AUM
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group's KRMD Position: Q4 2025 in Review

Vanguard Group increased its KORU Medical Systems (KRMD) stake by 2.9% in Q4 2025, buying an estimated $297K and bringing the position to 2,207,698 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Vanguard Group first reported a position in KRMD in Q4 2019 and has held it in 25 quarters since. 84 funds tracked by Wall St. Rank hold KRMD as of Q4 2025.

  • Vanguard Group held 2,207,698 shares of KORU Medical Systems worth $12.8M as of Q4 2025.
  • Vanguard Group bought 61,926 KORU Medical Systems shares in Q4 2025, an estimated $297K.
  • KORU Medical Systems made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2837 holding.
  • Vanguard Group first reported a position in KORU Medical Systems in Q4 2019 and has held it in 25 quarters since.
  • 84 funds tracked by Wall St. Rank held KORU Medical Systems as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.